Page 66 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 5 ฉบับที่ 2 (ฉบับเสริม)
P. 66

๕๘


                 OR-24


                 Ÿ¨…°Š­µ¦­„´—Á‡°¦r‡¼¤·œ (curcumin) ˜n°¡¥µ›·­£µ¡…°Š®œ¼Â±¤­Á˜°¦rš¸É˜·—ÁºÊ°¡¥µ›·ÄÅ¤o˜´

                 (Opisthorchis viverrini)Ÿnµœ„µ¦Â­—а°„…°Š¥¸œÁ„¸É¥ª…o°Š„´„µ¦˜µ¥ (apoptosis-related genes)

                 ›·—µ¦´˜œr »¤µ«, ž¦µ–¸ «¦¸¦µ, »«¦µ „oª­¤»š¦, Á˜º°œÄ‹ «¦¸­ªnµŠªŠ«r, Å¡¼¨¥r ­·š›·™µª¦
                 £µ‡ª·µž¦­·˜ª·¥µÂ¨³ «¼œ¥rª·‹´¥¡¥µ›·ÄÅ¤o˜´Â¨³¤³Á¦ÈŠšn°œÊε—¸ ‡–³Â¡š¥«µ­˜¦r ¤®µª·š¥µ¨´¥…°œÂ„nœ


                 ®¨´„„µ¦Â¨³Á®˜»Ÿ¨ „µ¦˜·—ÁºÊ°¡¥µ›·ÄÅ¤o˜´ (Opisthorchis viverrini) Á¦ºÊ°¦´ŠÁž}œž{‹‹´¥Á­¸É¥Š šÎµÄ®oÁ„·—

                 懤³Á¦ÈŠšn°œÊε—¸ ™¹ŠÂ¤o‹³¤¸¥µ¡¦µŽ·‡ªµœÁš¨š¸É¤¸ž¦³­·š›·£µ¡Äœ„µ¦¦´„¬µ°»´˜·„µ¦–r„µ¦Á„·—懡¥µ›·
                 ĝŤo˜´Â¨³¤³Á¦ÈŠšn°œÊε—¸„Ȥ·Å—o¨—œo°¥¨Š °´œÁœºÉ°Š¤µ‹µ„¡§˜·„¦¦¤„µ¦¦·Ã£‡ž¨µ—·Ç­»„ǚεĮo¤¸„µ¦

                 ˜·—ÁºÊ°ŽÊε—´Šœ´Êœ „µ¦¨—¡¥µ›·­£µ¡š¸ÉÁ„·—…¹Êœ‹µ„„µ¦˜·—ÁºÊ°¡¥µ›·ÄÅ¤o˜´‹¹Š¤¸‡ªµ¤­Îµ‡´˜n°„µ¦¨—ž{‹‹´¥

                 Á­¸É¥Š…°Š„µ¦Á„·—¤³Á¦ÈŠšn°œÊε—¸

                 ª´˜™»ž¦³­Š‡r Á¡ºÉ°«¹„¬µŸ¨…°Š­µ¦­„´—Á‡°¦r‡¼¤·œ‹µ„…¤·Êœš¸É¤¸„µ¦Äo¡¦n®¨µ¥Â¨³¤¸­¦¦¡‡»–¨—„µ¦°´„Á­
                 ¨³°œ»¤¼¨°·­¦³ Ĝ„µ¦¨—¡¥µ›·­£µ¡…°Š®œ¼Â±¤­Á˜°¦rš¸É˜·—ÁºÊ°—oª¥¡¥µ›·ÄÅ¤o˜´Ÿnµœ„µ¦Â­—а°„…°Š

                 ¥¸œš¸ÉÁ„¸É¥ª…o°Š„´„µ¦˜µ¥ (apoptosis-related genes)

                 ª´­—»Â¨³ª·›¸„µ¦ «¹„¬µ¡¥µ›·­£µ¡Ã—¥„µ¦¥o°¤­¸ hematoxylin and eosin Áš‡œ·‡ reverse transcription PCR

                 (RT-PCR) ¨³„µ¦¥o°¤ TUNEL ץnŠ®œ¼Áž}œÓ„¨»n¤‡º°®œ¼Â±¤­Á˜°¦rš¸É˜·—ÁºÊ°—oª¥¡¥µ›·ÄÅ¤o˜´(OV)
                 ¨³®œ¼˜·—ÁºÊ°š¸ÉÄ®oÁ‡°¦r‡¼¤·œ (OV+Cur) Á„ȝ˜´ª°¥nµŠ·ÊœÁœºÊ°˜´…°Š®œ¼š¸ÉÁª¨µ˜nµŠ Ç „´œ (Ø, ÒÕ, ÓÒ, ÔÑ,

                 ×Ѩ³ ÚѪ´œ®¨´Š„µ¦˜·—ÁºÊ°) ×¥š´ÊŠ­°Š„¨»n¤¤¸®œ¼„¨»n¤‡ª‡»¤ž„˜· (N) ¨³Å—o¦´Á‡°¦r‡¼¤·œ (N+Cur)

                 Ÿ¨„µ¦«¹„¬µ ¨´„¬–³šµŠ„µ¥ª·£µ‡…°Š˜´¡ªnµšn°œÊε—¸…°Š®œ¼Â±¤­Á˜°¦rš¸É˜·—ÁºÊ°¡¥µ›·š´ÊŠ­°Š„¨»n¤¤¸„µ¦
                 ®œµ˜´ª…¹Êœ˜µ¤¦³¥³Áª¨µ„µ¦˜·—ÁºÊ°­nªœ„µ¦«¹„¬µ¡¥µ›·­£µ¡…°Š¦·Áª–¦° Ç šn°œÊε—¸…°Š˜´Ã—¥„µ¦

                 ¥o°¤­¸ ¡ªnµ„µ¦Á…oµ¤µ…°ŠÁލ¨r°´„Á­¦° Ç šn°œÊε—¸¤¸‡ªµ¤­´¤¡´œ›r„´¦³—´„µ¦Â­—а°„…°Š¥¸œÂ¨³

                 ¡ªnµÁލ¨r°´„Á­¤¸ÂœªÃœo¤¨—¨ŠÄœ„¨»n¤š¸Éŗo¦´Á‡°¦r‡¼¤·œÂ˜nŤn¤¸œ´¥­Îµ‡´Á¤ºÉ°˜¦ª‹ª´—„µ¦Â­—а°„…°Š
                 ¥¸œÄœ¦³—´ mRNA …°Š¥¸œ Bcl-2 associated protein X (BAX), tumor suppressor gene (p53), caspase 9,

                 smad1 ¨³ smad4 Ž¹ÉŠÁž}œ¥¸œš¸ÉÁ„¸É¥ª…o°Š„´„µ¦Á„·— apoptotic  ¨³ serine/threonine protein kinase (PKB)

                 mouse double minute 2 (MDM2) ¨³ c-ski (oncogene) Ž¹ÉŠÁž}œ anti-apoptotic genes ×¥°µ«´¥Áš‡œ·‡ RT-

                 PCR ¡ªnµ „µ¦Â­—а°„…°Š¥¸œÄœš´ÊŠ­°Š„¨»n¤¤¸¦¼žÂš¸É‡¨oµ¥„´œ ×¥„µ¦Â­—а°„…°Š apoptosis-related
                 genes ‹³Á¦·É¤­¼Š…¹ÊœÄœª´œš¸É ØÂ¨³­¼Šš¸É­»—ž¦³¤µ–ª´œš¸É ÔÑ ®¨´Š˜·—ÁºÊ° ¨³‹³¨—¨Š®¨´Š‹µ„ª´œš¸É ×Ñ °¥nµŠ¤¸

                 œ´¥­Îµ‡´šµŠ­™·˜· (p<0.05)  Á¤ºÉ°Áž¦¸¥Áš¸¥®œ¼Äœ„¨»n¤ N+Cur  ¨³ N ¡ªnµ®œ¼Äœ„¨»n¤ OV+Cur ¤¸„µ¦

                 ­—а°„…°Š apoptotic  genes  ¨³ anti-apoptosis  ¤¸ÂœªÃœo¤¨—¨ŠÁ¤ºÉ°Áž¦¸¥Áš¸¥„´„¨»n¤ OV °¥nµŠ
                 ¤¸œ´¥­Îµ‡´šµŠ­™·˜· (p<0.05)  ‹µ„„µ¦¥o°¤ TUNEL  assay  ¡ªnµ¤¸„µ¦˜µ¥…°ŠÁލ¨rš¸Éœ·ªÁ‡¨¸¥­…°ŠÁލ¨r

                 Á¥ºÉ°»…°ŠŸœ´Ššn°œÊε—¸ ™»ŠœÊε—¸ ¨³Áލ¨r°´„Á­ Ĝ®œ¼š´ÊŠ­°Š„¨»n¤

                 …o°­¦»ž ‹µ„Ÿ¨„µ¦«¹„¬µ‡¦´ÊŠœ¸Ê‡µ—ªnµÁ‡°¦r‡¼¤·œœnµ‹³¤¸Ÿ¨¨—Áލ¨r°´„Á­ ¨—°œ»¤¼¨°·­¦³­nŠŸ¨Ä®o¨—¡¥µ›·

                 ­£µ¡š¸ÉÁ„·—‹µ„„µ¦˜·—ÁºÊ°¡¥µ›·ÄÅ¤o˜´Ÿnµœ„µ¦Â­—а°„…°Š¥¸œš¸ÉÁ„¸É¥ª…o°Š„´„µ¦Á„·— apoptosis Ž¹ÉŠ­nŠŸ¨
                 ˜n°„µ¦¨—ž{‹‹´¥Á­¸É¥ŠÄœ„µ¦¡´•œµ„µ¦Á„·—懚µŠ¦³œÊε—¸ ¦ª¤š´ÊФ³Á¦ÈŠšn°œÊε—¸
   61   62   63   64   65   66   67   68   69   70   71